Skin Cancer Diagnostics Market

Global Skin Cancer Diagnostics Market Size, Share & Trends Analysis Report By Type (Non-Melanoma and Melanoma), By Test Type (Skin Biopsy, Imaging Tests, Dermatoscopy, Lymph Node Biopsy, and Others), ByEnd-use, By Regional Outlook and Forecast, 2024 - 2031

Report Id: KBV-23729 Publication Date: July-2024 Number of Pages: 219
2023
USD 8.6 Billion
2031
USD 12.8 Billion
CAGR
5.3%
Historical Data
2020 to 2022
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Skin Cancer Diagnostics Market, by Type
1.4.2 Global Skin Cancer Diagnostics Market, by Test Type
1.4.3 Global Skin Cancer Diagnostics Market, by End-use
1.4.4 Global Skin Cancer Diagnostics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Global Skin Cancer Diagnostics Market by Type
4.1 Global Non-Melanoma Market by Region
4.2 Global Melanoma Market by Region

Chapter 5. Global Skin Cancer Diagnostics Market by Test Type
5.1 Global Skin Biopsy Market by Region
5.2 Global Imaging Tests Market by Region
5.3 Global Dermatoscopy Market by Region
5.4 Global Lymph Node Biopsy Market by Region
5.5 Global Others Market by Region

Chapter 6. Global Skin Cancer Diagnostics Market by End-use
6.1 Global Hospital & Clinics Market by Region
6.2 Global Laboratories Market by Region
6.3 Global Others Market by Region

Chapter 7. Global Skin Cancer Diagnostics Market by Region
7.1 North America Skin Cancer Diagnostics Market
7.1.1 North America Skin Cancer Diagnostics Market by Type
7.1.1.1 North America Non-Melanoma Market by Country
7.1.1.2 North America Melanoma Market by Country
7.1.2 North America Skin Cancer Diagnostics Market by Test Type
7.1.2.1 North America Skin Biopsy Market by Country
7.1.2.2 North America Imaging Tests Market by Country
7.1.2.3 North America Dermatoscopy Market by Country
7.1.2.4 North America Lymph Node Biopsy Market by Country
7.1.2.5 North America Others Market by Country
7.1.3 North America Skin Cancer Diagnostics Market by End-use
7.1.3.1 North America Hospital & Clinics Market by Country
7.1.3.2 North America Laboratories Market by Country
7.1.3.3 North America Others Market by Country
7.1.4 North America Skin Cancer Diagnostics Market by Country
7.1.4.1 US Skin Cancer Diagnostics Market
7.1.4.1.1 US Skin Cancer Diagnostics Market by Type
7.1.4.1.2 US Skin Cancer Diagnostics Market by Test Type
7.1.4.1.3 US Skin Cancer Diagnostics Market by End-use
7.1.4.2 Canada Skin Cancer Diagnostics Market
7.1.4.2.1 Canada Skin Cancer Diagnostics Market by Type
7.1.4.2.2 Canada Skin Cancer Diagnostics Market by Test Type
7.1.4.2.3 Canada Skin Cancer Diagnostics Market by End-use
7.1.4.3 Mexico Skin Cancer Diagnostics Market
7.1.4.3.1 Mexico Skin Cancer Diagnostics Market by Type
7.1.4.3.2 Mexico Skin Cancer Diagnostics Market by Test Type
7.1.4.3.3 Mexico Skin Cancer Diagnostics Market by End-use
7.1.4.4 Rest of North America Skin Cancer Diagnostics Market
7.1.4.4.1 Rest of North America Skin Cancer Diagnostics Market by Type
7.1.4.4.2 Rest of North America Skin Cancer Diagnostics Market by Test Type
7.1.4.4.3 Rest of North America Skin Cancer Diagnostics Market by End-use
7.2 Europe Skin Cancer Diagnostics Market
7.2.1 Europe Skin Cancer Diagnostics Market by Type
7.2.1.1 Europe Non-Melanoma Market by Country
7.2.1.2 Europe Melanoma Market by Country
7.2.2 Europe Skin Cancer Diagnostics Market by Test Type
7.2.2.1 Europe Skin Biopsy Market by Country
7.2.2.2 Europe Imaging Tests Market by Country
7.2.2.3 Europe Dermatoscopy Market by Country
7.2.2.4 Europe Lymph Node Biopsy Market by Country
7.2.2.5 Europe Others Market by Country
7.2.3 Europe Skin Cancer Diagnostics Market by End-use
7.2.3.1 Europe Hospital & Clinics Market by Country
7.2.3.2 Europe Laboratories Market by Country
7.2.3.3 Europe Others Market by Country
7.2.4 Europe Skin Cancer Diagnostics Market by Country
7.2.4.1 Germany Skin Cancer Diagnostics Market
7.2.4.1.1 Germany Skin Cancer Diagnostics Market by Type
7.2.4.1.2 Germany Skin Cancer Diagnostics Market by Test Type
7.2.4.1.3 Germany Skin Cancer Diagnostics Market by End-use
7.2.4.2 UK Skin Cancer Diagnostics Market
7.2.4.2.1 UK Skin Cancer Diagnostics Market by Type
7.2.4.2.2 UK Skin Cancer Diagnostics Market by Test Type
7.2.4.2.3 UK Skin Cancer Diagnostics Market by End-use
7.2.4.3 France Skin Cancer Diagnostics Market
7.2.4.3.1 France Skin Cancer Diagnostics Market by Type
7.2.4.3.2 France Skin Cancer Diagnostics Market by Test Type
7.2.4.3.3 France Skin Cancer Diagnostics Market by End-use
7.2.4.4 Russia Skin Cancer Diagnostics Market
7.2.4.4.1 Russia Skin Cancer Diagnostics Market by Type
7.2.4.4.2 Russia Skin Cancer Diagnostics Market by Test Type
7.2.4.4.3 Russia Skin Cancer Diagnostics Market by End-use
7.2.4.5 Spain Skin Cancer Diagnostics Market
7.2.4.5.1 Spain Skin Cancer Diagnostics Market by Type
7.2.4.5.2 Spain Skin Cancer Diagnostics Market by Test Type
7.2.4.5.3 Spain Skin Cancer Diagnostics Market by End-use
7.2.4.6 Italy Skin Cancer Diagnostics Market
7.2.4.6.1 Italy Skin Cancer Diagnostics Market by Type
7.2.4.6.2 Italy Skin Cancer Diagnostics Market by Test Type
7.2.4.6.3 Italy Skin Cancer Diagnostics Market by End-use
7.2.4.7 Rest of Europe Skin Cancer Diagnostics Market
7.2.4.7.1 Rest of Europe Skin Cancer Diagnostics Market by Type
7.2.4.7.2 Rest of Europe Skin Cancer Diagnostics Market by Test Type
7.2.4.7.3 Rest of Europe Skin Cancer Diagnostics Market by End-use
7.3 Asia Pacific Skin Cancer Diagnostics Market
7.3.1 Asia Pacific Skin Cancer Diagnostics Market by Type
7.3.1.1 Asia Pacific Non-Melanoma Market by Country
7.3.1.2 Asia Pacific Melanoma Market by Country
7.3.2 Asia Pacific Skin Cancer Diagnostics Market by Test Type
7.3.2.1 Asia Pacific Skin Biopsy Market by Country
7.3.2.2 Asia Pacific Imaging Tests Market by Country
7.3.2.3 Asia Pacific Dermatoscopy Market by Country
7.3.2.4 Asia Pacific Lymph Node Biopsy Market by Country
7.3.2.5 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Skin Cancer Diagnostics Market by End-use
7.3.3.1 Asia Pacific Hospital & Clinics Market by Country
7.3.3.2 Asia Pacific Laboratories Market by Country
7.3.3.3 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Skin Cancer Diagnostics Market by Country
7.3.4.1 China Skin Cancer Diagnostics Market
7.3.4.1.1 China Skin Cancer Diagnostics Market by Type
7.3.4.1.2 China Skin Cancer Diagnostics Market by Test Type
7.3.4.1.3 China Skin Cancer Diagnostics Market by End-use
7.3.4.2 Japan Skin Cancer Diagnostics Market
7.3.4.2.1 Japan Skin Cancer Diagnostics Market by Type
7.3.4.2.2 Japan Skin Cancer Diagnostics Market by Test Type
7.3.4.2.3 Japan Skin Cancer Diagnostics Market by End-use
7.3.4.3 India Skin Cancer Diagnostics Market
7.3.4.3.1 India Skin Cancer Diagnostics Market by Type
7.3.4.3.2 India Skin Cancer Diagnostics Market by Test Type
7.3.4.3.3 India Skin Cancer Diagnostics Market by End-use
7.3.4.4 South Korea Skin Cancer Diagnostics Market
7.3.4.4.1 South Korea Skin Cancer Diagnostics Market by Type
7.3.4.4.2 South Korea Skin Cancer Diagnostics Market by Test Type
7.3.4.4.3 South Korea Skin Cancer Diagnostics Market by End-use
7.3.4.5 Singapore Skin Cancer Diagnostics Market
7.3.4.5.1 Singapore Skin Cancer Diagnostics Market by Type
7.3.4.5.2 Singapore Skin Cancer Diagnostics Market by Test Type
7.3.4.5.3 Singapore Skin Cancer Diagnostics Market by End-use
7.3.4.6 Malaysia Skin Cancer Diagnostics Market
7.3.4.6.1 Malaysia Skin Cancer Diagnostics Market by Type
7.3.4.6.2 Malaysia Skin Cancer Diagnostics Market by Test Type
7.3.4.6.3 Malaysia Skin Cancer Diagnostics Market by End-use
7.3.4.7 Rest of Asia Pacific Skin Cancer Diagnostics Market
7.3.4.7.1 Rest of Asia Pacific Skin Cancer Diagnostics Market by Type
7.3.4.7.2 Rest of Asia Pacific Skin Cancer Diagnostics Market by Test Type
7.3.4.7.3 Rest of Asia Pacific Skin Cancer Diagnostics Market by End-use
7.4 LAMEA Skin Cancer Diagnostics Market
7.4.1 LAMEA Skin Cancer Diagnostics Market by Type
7.4.1.1 LAMEA Non-Melanoma Market by Country
7.4.1.2 LAMEA Melanoma Market by Country
7.4.2 LAMEA Skin Cancer Diagnostics Market by Test Type
7.4.2.1 LAMEA Skin Biopsy Market by Country
7.4.2.2 LAMEA Imaging Tests Market by Country
7.4.2.3 LAMEA Dermatoscopy Market by Country
7.4.2.4 LAMEA Lymph Node Biopsy Market by Country
7.4.2.5 LAMEA Others Market by Country
7.4.3 LAMEA Skin Cancer Diagnostics Market by End-use
7.4.3.1 LAMEA Hospital & Clinics Market by Country
7.4.3.2 LAMEA Laboratories Market by Country
7.4.3.3 LAMEA Others Market by Country
7.4.4 LAMEA Skin Cancer Diagnostics Market by Country
7.4.4.1 Brazil Skin Cancer Diagnostics Market
7.4.4.1.1 Brazil Skin Cancer Diagnostics Market by Type
7.4.4.1.2 Brazil Skin Cancer Diagnostics Market by Test Type
7.4.4.1.3 Brazil Skin Cancer Diagnostics Market by End-use
7.4.4.2 Argentina Skin Cancer Diagnostics Market
7.4.4.2.1 Argentina Skin Cancer Diagnostics Market by Type
7.4.4.2.2 Argentina Skin Cancer Diagnostics Market by Test Type
7.4.4.2.3 Argentina Skin Cancer Diagnostics Market by End-use
7.4.4.3 UAE Skin Cancer Diagnostics Market
7.4.4.3.1 UAE Skin Cancer Diagnostics Market by Type
7.4.4.3.2 UAE Skin Cancer Diagnostics Market by Test Type
7.4.4.3.3 UAE Skin Cancer Diagnostics Market by End-use
7.4.4.4 Saudi Arabia Skin Cancer Diagnostics Market
7.4.4.4.1 Saudi Arabia Skin Cancer Diagnostics Market by Type
7.4.4.4.2 Saudi Arabia Skin Cancer Diagnostics Market by Test Type
7.4.4.4.3 Saudi Arabia Skin Cancer Diagnostics Market by End-use
7.4.4.5 South Africa Skin Cancer Diagnostics Market
7.4.4.5.1 South Africa Skin Cancer Diagnostics Market by Type
7.4.4.5.2 South Africa Skin Cancer Diagnostics Market by Test Type
7.4.4.5.3 South Africa Skin Cancer Diagnostics Market by End-use
7.4.4.6 Nigeria Skin Cancer Diagnostics Market
7.4.4.6.1 Nigeria Skin Cancer Diagnostics Market by Type
7.4.4.6.2 Nigeria Skin Cancer Diagnostics Market by Test Type
7.4.4.6.3 Nigeria Skin Cancer Diagnostics Market by End-use
7.4.4.7 Rest of LAMEA Skin Cancer Diagnostics Market
7.4.4.7.1 Rest of LAMEA Skin Cancer Diagnostics Market by Type
7.4.4.7.2 Rest of LAMEA Skin Cancer Diagnostics Market by Test Type
7.4.4.7.3 Rest of LAMEA Skin Cancer Diagnostics Market by End-use

Chapter 8. Company Profiles
8.1 Castle Biosciences, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.1.4.2 Acquisition and Mergers:
8.1.5 SWOT Analysis
8.2 Bausch Health Companies, Inc.(DermTech, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Canfield Scientific, Inc.
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 DermaSensor, Inc.
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Neogenomics, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Quest Diagnostics Incorporated
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Recent strategies and developments:
8.7.4.1 Partnerships, Collaborations, and Agreements:
8.7.4.2 Acquisition and Mergers:
8.7.5 SWOT Analysis
8.8 Digital Diagnostics, Inc.(3Derm Systems, Inc.)
8.8.1 Company Overview
8.9 FotoFinder Systems GmbH
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. VERISKIN INC.
8.10.1 Company Overview
8.10.2 SWOT Analysis

Chapter 9. Winning Imperatives for Skin Cancer Diagnostics Market
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo